Cyclophosphamide has been approved for certain kinds of cancer, and Nexus had been pursuing a generic version to offer to patients. Ingenus Pharmaceuticals sued Nexus for patent infringement. A ...

The Food and Drug Administration is warning consumers to steer clear of weight loss drugs sold through compounding pharmacies, some of which are brazenly being marketed as “generic” Ozempic and Wegovy ...

We may receive a commission on purchases made from links. If that's not appealing to you, you might consider looking for third-party, generic alternatives. For what it's worth, there is a ...

Mounjaro does not have FDA approval for weight loss, but the organization has approved Wegovy (semaglutide ... pens, which is a 1-month supply. The FDA has not yet approved using generic ...

Zydus is in the middle of clinical trials in India for the single pen device and the regulatory examination process is ongoing, the person said. "Our current strategy for semaglutide, both for India ...

Sports Mole previews Sunday's Eredivisie clash between AZ Alkmaar and FC Twente, including predictions, team news and possible lineups. After back-to-back seasons finishing in the top four of the ...

Together, Novo Nordisk and Eli Lilly sold more than $40 billion worth of GLP-1 drugs ... How does Novo Nordisk plan to compete with generic semaglutide once patents expire?

By August, some analysts were estimating that Zepbound had captured 40% of the U.S. weight loss ... exclusivity and drugmakers can sell cheaper generic alternatives. For example, Novo Nordisk ...